Molecular Analysis of Thymopentin Binding to HLA-DR Molecules
2007

How Thymopentin Binds to HLA-DR Molecules

publication Evidence: moderate

Author Information

Author(s): Liu Zuojia, Zheng Xiliang, Wang Jin, Wang Erkang

Primary Institution: State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences

Hypothesis

Thymopentin (TP5) must form a complex with human class II major histocompatibility complex DR molecules (HLA-DR) before it interacts with T cells.

Conclusion

The study demonstrated that TP5 can bind to HLA-DR in living antigen presenting cells, providing insights into its immunomodulatory mechanism.

Supporting Evidence

  • TP5 was shown to directly bind to HLA-DR molecules on the surface of EBV-transformed B cells.
  • The binding specificity of TP5 was confirmed through competitive binding assays.
  • Molecular modeling indicated that specific amino acids in TP5 are crucial for its binding to HLA-DR.

Takeaway

Thymopentin helps the immune system by sticking to certain molecules on cells, which is important for how it works.

Methodology

The study used confocal-laser scanning microscopy and flow cytometry to examine the binding of fluorescent-labeled TP5 to HLA-DR in living cells.

Statistical Information

P-Value

7.2×10−6 M

Digital Object Identifier (DOI)

10.1371/journal.pone.0001348

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication